Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
Home › Stocks › UnitedHealth Group Incorporated (UNH) Stock Forecast & Price Prediction United States | NYSE | Healthcare | Healthcare Plans
$302.98
-18.60 (-5.78%)10 Quality Stocks Worth Considering Now
Researching UnitedHealth (UNH) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on UNH and similar high-potential opportunities.
Based on our analysis of 48 Wall Street analysts, UNH has a bullish consensus with a median price target of $374.00 (ranging from $270.00 to $626.00). The overall analyst rating is Strong Buy (8.4/10). Currently trading at $302.98, the median forecast implies a 23.4% upside. This outlook is supported by 20 Buy, 5 Hold, and 2 Sell ratings.
Conversely, the most conservative target is provided by Sidharth Sahoo at HSBC, suggesting a 10.9% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for UNH.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
May 21, 2025 | HSBC | Sidharth Sahoo | Reduce | Downgrade | $270.00 |
May 20, 2025 | Wolfe Research | Justin Lake | Outperform | Maintains | $390.00 |
May 19, 2025 | Truist Securities | David Macdonald | Buy | Reiterates | $360.00 |
May 19, 2025 | TD Securities | Ryan Langston | Hold | Downgrade | $308.00 |
May 16, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $355.00 |
May 16, 2025 | Mizuho | Ann Hynes | Outperform | Maintains | $350.00 |
May 15, 2025 | Barclays | Andrew Mok | Overweight | Maintains | $362.00 |
May 15, 2025 | JP Morgan | Lisa Gill | Overweight | Maintains | $405.00 |
May 14, 2025 | Keybanc | Matthew Gillmor | Overweight | Maintains | $450.00 |
May 14, 2025 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $351.00 |
May 14, 2025 | Deutsche Bank | George Hill | Buy | Maintains | $362.00 |
May 14, 2025 | Morgan Stanley | Ricky Goldwasser | Overweight | Maintains | $374.00 |
May 14, 2025 | Oppenheimer | Michael Wiederhorn | Outperform | Maintains | $400.00 |
May 14, 2025 | Baird | Michael Ha | Outperform | Maintains | $356.00 |
May 14, 2025 | B of A Securities | Kevin Fischbeck | Neutral | Downgrade | $350.00 |
Apr 29, 2025 | Baird | Michael Ha | Outperform | Maintains | $510.00 |
Apr 24, 2025 | JP Morgan | Lisa Gill | Overweight | Maintains | $525.00 |
Apr 24, 2025 | Barclays | Andrew Mok | Overweight | Maintains | $513.00 |
Apr 23, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $525.00 |
Apr 22, 2025 | Morgan Stanley | Ricky Goldwasser | Overweight | Maintains | $563.00 |
The following stocks are similar to UnitedHealth based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
UnitedHealth Group Incorporated has a market capitalization of $270.53B with a P/E ratio of 12.5x. The company generates $410.06B in trailing twelve-month revenue with a 5.4% profit margin.
Revenue growth is +9.8% quarter-over-quarter, while maintaining an operating margin of +8.3% and return on equity of +22.7%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Diversified healthcare services and products provider.
The company operates through two main segments: UnitedHealthcare, which offers healthcare benefits, and Optum, which delivers health services utilizing technology and information. It generates revenue by providing insurance coverage, managing health services, and partnering with government agencies, employers, and individual consumers.
UnitedHealth Group is a key player in the healthcare industry and is included in the Dow Jones Industrial Average, highlighting its significant market influence. The company focuses on improving community health outcomes and managing healthcare costs.
Healthcare
Healthcare Plans
400,000
Sir Andrew Philip Witty
United States
1990
UnitedHealth, Centene and Molina Healthcare are part of the Zacks top Analyst Blog.
Does UnitedHealth's Insiders scooping up shares of UNH justify a buy decision today? Let's explore -
UnitedHealth Group are part of the Zacks Investment Ideas article.
UnitedHealth shares dropped nearly 7% in premarket trading following a report that it paid nursing homes bonuses to reduce hospital transfers for residents.
UnitedHealth's stock drop reflects concerns over potential regulatory scrutiny and reputational damage, which can affect future earnings and investor confidence.
UnitedHealthcare, the largest U.S. insurer, faces increased public and political scrutiny, reflecting broader issues within the insurance industry and healthcare system.
UnitedHealthcare's scrutiny highlights systemic issues in the insurance industry, potentially impacting regulatory changes and investor sentiment towards health insurers.
UnitedHealth Group (UNH) has shown strong resilience, operating the largest health insurance business in the U.S. and being the second-largest pharmacy benefits manager.
UnitedHealth Group's resilience indicates strong market positioning and stability, potentially attracting investors seeking reliable growth in the healthcare sector.
UnitedHealth Group's shares fell 5.8%, underperforming the S&P 500 and Nasdaq, which dropped 1.6% and 1.4%, respectively, at market close on Wednesday.
UnitedHealth's significant drop in share price, exceeding broader market losses, signals potential underlying issues, affecting investor confidence and future performance expectations.
UnitedHealth Group's stock declined following reports that the insurer covertly paid nursing homes to decrease hospital transfers.
UnitedHealth's stock decline signals potential regulatory scrutiny and reputational damage, which may affect future earnings and investor confidence.
UnitedHealth Group Inc (NYSE: UNH) is experiencing a significant decline as investors are selling off shares following a series of negative developments.
The decline of UnitedHealth Group signals eroding investor confidence, potentially impacting stock performance and influencing broader healthcare sector trends.
Based on our analysis of 48 Wall Street analysts, UnitedHealth Group Incorporated (UNH) has a median price target of $374.00. The highest price target is $626.00 and the lowest is $270.00.
According to current analyst ratings, UNH has 20 Buy ratings, 5 Hold ratings, and 2 Sell ratings. The stock is currently trading at $302.98. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict UNH stock could reach $374.00 in the next 12 months. This represents a 23.4% increase from the current price of $302.98. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company operates through two main segments: UnitedHealthcare, which offers healthcare benefits, and Optum, which delivers health services utilizing technology and information. It generates revenue by providing insurance coverage, managing health services, and partnering with government agencies, employers, and individual consumers.
The highest price target for UNH is $626.00 from at , which represents a 106.6% increase from the current price of $302.98.
The lowest price target for UNH is $270.00 from Sidharth Sahoo at HSBC, which represents a -10.9% decrease from the current price of $302.98.
The overall analyst consensus for UNH is bullish. Out of 48 Wall Street analysts, 20 rate it as Buy, 5 as Hold, and 2 as Sell, with a median price target of $374.00.
Stock price projections, including those for UnitedHealth Group Incorporated, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.